Corporate wellness vendors in 2026 fall into two camps traditional step-counting platforms and outcome-tracked holistic programs. Wellable Limeade and Virgin Pulse dominate the first. The second is wide open.
The Wellable Model
Wellable is the largest platform-agnostic wellness software. Covers health insurance carriers and self-insured employers. Integrates fitness trackers and biometric devices. Gamified challenges leaderboards and social features drive engagement.
What it measures: Steps sleep water logged food mood checkins.
What it does not measure: Biomarkers. Metabolic outcomes. Cortisol HRV insulin sensitivity. Actual health improvement.
Cost: 5-8 per employee per month for 500+ employees. Often bundled with insurance carriers at lower employee cost.
Outcome data: Engagement metrics only. No clinical outcomes published. Most Wellable customers report 10-20 percent participation and no measurable health improvement after two years.
The Limeade Model
Limeade is similar to Wellable with more emphasis on behavioral coaching and digital therapy content. Integrates EAP employee assistance programs.
What it adds over Wellable: Coaching modules digital therapists behavioral incentives.
What it still misses: Functional labs. Biomarker tracking. Accountability for actual health metrics.
Cost: 8-12 per employee per month.
Outcome data: Similar to Wellable engagement without clinical validation.
The Virgin Pulse Model
Virgin Pulse owns several platforms through acquisition. Offers white-label wellness programs integrates biometric devices and wearables.
What differentiates it: Scale. Enterprise integration. Biometric data capture from multiple device brands.
What it still does not do: Clinical interpretation. Functional medicine labs. Root-cause diagnostics.
Cost: 10-15 per employee per month depending on features.
Outcome data: Heavy on engagement metrics. Limited clinical efficacy data.
What All Three Platforms Miss
None of these platforms track the metrics that actually move health in a corporate setting: cortisol rhythm HRV fasting insulin hs-CRP. They track inputs steps calories water. They do not track outputs health improvement.
A CEO with a 10000-step daily average and excellent Wellable engagement can still have a flat cortisol rhythm and metabolic syndrome. Wellable will congratulate them. A functional medicine program will say they have a problem and design a protocol to fix it.
The Outcome-Tracked Holistic Model
An outcome-tracked holistic program baseline-measures actual health markers cortisol HRV insulin sensitivity hs-CRP. Designs interventions acupuncture herbal medicine functional labs. Re-measures at 90 days. Reports measurable improvement or explains why the intervention needs adjustment.
Cost: 50-150 per employee per month depending on depth but actual health outcomes justify the cost.
Outcome data: Measurable HRV improvement cortisol normalization insulin sensitivity gains. Quantifiable health recovery not engagement vanity metrics.
Risk to Watch in 2026: The April 30 FDA 503B GLP-1 Exclusion Proposal
On April 30, 2026, the FDA proposed adding semaglutide and tirzepatide to the 503B Bulks List exclusion — meaning bulk-compounded GLP-1 supply through 503B outsourcing facilities would end if finalized. The 60-day public comment period closes June 29, 2026; most regulatory analysts expect finalization by late 2026 or early 2027.
For HR buyers running GLP-1-heavy benefits programs, this is structural risk you must surface in any 2026 RFP.
Vendor exposure: Brand-name-prescribing telehealth (Ro, Hims, Sesame) = low exposure (source through standard pharmacies). 503B-sourced compounded GLP-1 telehealth (eMed, MEDVi, TWC, Henry Meds, Mochi) = high exposure (compounded GLP-1 is meaningful revenue share; supply chain risk). In-clinic concierge (Forward, Lifeforce) = variable (depends on 503A vs 503B sourcing). Outcome-tracked holistic = none (does not prescribe GLP-1; coordinates with patient’s clinician).
Two questions for your 2026 RFP: (1) Where does your GLP-1 medication come from — 503A patient-specific, 503B outsourcing, or brand-name through standard pharmacy? (2) What is your contingency plan if 503B supply ends in late 2026?
Why outcome-tracked holistic becomes more valuable: GLP-1-only programs face supply uncertainty. Outcome-tracked holistic programs focus on integrative metabolic-support — Akkermansia probiotics, sleep optimization, Mediterranean protein anchoring, resistance training, post-GLP-1 muscle-loss prevention — insulated from Apr 30 risk and more valuable when medication supply gets uncertain.
Conclusion
Wellable Limeade and Virgin Pulse are engagement platforms. They move the needle on participation. They do not move the needle on health. An outcome-tracked holistic program costs more but delivers what every CEO actually wants measurable health improvement.
Dr. Brandon Bright, DAOM, LAc
Holistic and integrative medicine practitioner serving Tustin and patients nationwide.